Universal Biosensors Inc Share Price and Company Fundamentals
Last traded: Today at 2:00 AM
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It offers SENTIA Wine Analyzer to test Free Sulphur Dioxide; prothrombin time international normalized ratio coagulation test strips; Sentia Free Sulphite test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.
|Primary activities||The Company is a specialist medical diagnostics company focused on the development, manufacture and commercialisation of a range of in vitro diagnostic tests for point-of-care use.|
|Industry / Sector||Medical Devices / Healthcare|
|Full time employees||60|
|Mailing address||1 Corporate Avenue Rowville VIC 3178 Australia|
|Phone / Fax||61 3 9213 9000 / 61 3 9213 9099|
|Share registry||BOARDROOM PTY LIMITED|
Universal Biosensors Inc does not pay dividends.
As of Jan 2022, following are the company executives and directors listed on Universal Biosensors Inc.
|Mr. John Stewart Sharman B Ec, CA, M.App.Fin||Chief Exec. Officer||55||507.22k|
|Mr. Salesh Balak BA, CA||CFO & Company Sec.||52||571.19k|
|Mr. Nicholas Bliesner||Head of Operations|
|Ms. Ann Chew||Head of HR & Internal Audit|
|Mr. Luke Cossins||Head of R&D|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Universal Biosensors Inc is and its enterprise value is .
The UBI's stocks Beta value is 1.02 making it 2% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Universal Biosensors Inc (UBI)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Universal Biosensors Inc (ASX:UBI) Frequently Asked Questions
1. What is Universal Biosensors Inc's Stock Symbol?
Universal Biosensors Inc trades on ASX under the ticker symbol "UBI".
2. What is Universal Biosensors Inc's stock price today?
One share of UBI stock can currently be purchased for approximately $0.845.
3. How can I contact Universal Biosensors Inc?
Universal Biosensors Inc's mailing address is 1 Corporate Avenue Rowville VIC 3178 Australia. The company can be reached via phone at 61 3 9213 9000.
4. What is Universal Biosensors Inc's official website?
The official website of Universal Biosensors Inc is https://www.universalbiosensors.com.
5. Which share registry manages Universal Biosensors Inc's stock?
Universal Biosensors Inc's stock is managed by BOARDROOM PTY LIMITED.